Sbarbati R, de Boer M, Marzilli M, Scarlattini M, Rossi G, van Mourik J A
C.N.R. Institute of Clinical Physiology, Pisa, Italy.
Blood. 1991 Feb 15;77(4):764-9.
In this report we show that human endothelial cells (EC) can be detected in circulating blood by means of the EC-specific monoclonal antibody (MoAb) designated as CLB-HEC 19 and expressed quantitatively as number of cells per milliliter of whole blood. We first developed a method that was able to recover cultured human EC added to whole blood by Percoll density gradient centrifugation. The final recovery of the EC was 91.6% (SE = 0.65%). The EC were identified in the gradient subfractions by indirect immunofluorescence with the MoAb CLB-HEC 19. This method was then applied to the separation and characterization of EC or EC remnants from the whole arterial and venous blood taken from two groups of patients subjected to heart catheterization. Firstly, a preliminary blood screening of random samples was performed in a group of eight patients (group I) using a scoring evaluation for the presence of EC and the results were expressed as positivity index. Secondly, the complete blood screening of a group of ten patients (group II) was performed for the detection of immunofluorescent cells and the results were expressed as number of EC per milliliter of whole blood. Our results show in both group I and II a significant presence of EC in the blood after catheterization compared with their basal values. The minimal detectable concentration of EC was 0.06 cells/mL (SE = 0.057) of whole blood. We consider this technique as a suitable clinical test for the detection of EC injury in cardiovascular pathology.
在本报告中,我们表明可通过名为CLB-HEC 19的内皮细胞特异性单克隆抗体(MoAb)在循环血液中检测人内皮细胞(EC),并以每毫升全血中的细胞数进行定量表达。我们首先开发了一种方法,该方法能够通过Percoll密度梯度离心从添加到全血中的培养人内皮细胞中回收细胞。内皮细胞的最终回收率为91.6%(标准误=0.65%)。通过用MoAb CLB-HEC 19进行间接免疫荧光在梯度亚组分中鉴定内皮细胞。然后将该方法应用于从两组接受心脏导管插入术的患者采集的全动脉血和静脉血中分离和鉴定内皮细胞或内皮细胞残余物。首先,对一组8名患者(I组)的随机样本进行初步血液筛查,使用对内皮细胞存在情况的评分评估,结果以阳性指数表示。其次,对一组10名患者(II组)进行全血筛查以检测免疫荧光细胞,结果以每毫升全血中的内皮细胞数表示。我们的结果显示,与基础值相比,I组和II组患者在导管插入术后血液中均存在大量内皮细胞。内皮细胞的最低可检测浓度为每毫升全血0.06个细胞(标准误=0.057)。我们认为该技术是检测心血管疾病中内皮细胞损伤的一种合适的临床检测方法。